Based in the United States, Atterx Biotherapeutics is a startup.
Atterx Biotherapeutics develops novel treatments aimed at preventing and treating antibiotic-resistant bacterial infections, including solutions targeting catheter-associated urinary tract infections and gram-negative bacterial infections.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.